NSAIDs and Gout Flashcards

1
Q

NSAIDs - MoA

A

Inhibition of prostaglandin synthesis by competitive cyclooxygenase (COX) inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

NSAIDs - Clinical use

A
Low dose: mild-moderate pain, antipyretic
Higher doses: inflammation.
Postop pain (often combined with opioid)
Chronic pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAIDs - Contraindications

A

Avoid treatment with two NSAIDs (increased GI bleeding risk).

Generally not recommended for second half of pregnancy

Previous severe hypersensitivity to salicylates (cross-sensitivity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NSAIDs - Adverse

A
GI bleeding, peptic ulcers, renal & hepatic dysfunction.
Lithium toxicity.
Hyperkalemia
Platelet inhibition
Premature closure of ductus arteriosus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

NSAIDs - Interactions

A

Inhibit renal excretion of lithium.

Reduced clearance of aminoglycosides & methotrexates.

Interfere with antihypertensive effect of: diuretics, β-adrenoceptor antagonists, angiotensin inhibitors & others.

Potassium-sparing diuretics: hyperkalemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Salicylates - MoA

A

Nonspecific inhibition of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Salicylates - Clinical use

A

Pain, fever, inflammation

Prophylaxis for MI, stroke, thromboembolic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Salicylates - Contraindications and Overdose treatment

A

Avoid in children: Reye syndrome (in virus infected children).

Overdose treatment: 
Vomiting
IV sodium bicarbonate (alkalization of the urine, increases ionization and elimination)
Fluids
Electrolytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Salicylates - Adverse

A

Reye syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Salicylates - Interaction

A

Hypoglycemic effect alter antidiabetic drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aspirin - MoA

A

Forms covalent, irreversible inhibition of COX in platelets

Nonspecific inh of COX in peripheral tissues and CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aspirin - Clinical use

A

Analgesic
Antipyretic
Anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aspirin - Adverse

A

Aspirin toxicity

High dose:
Tinnitus (early sign of salicylate toxicity)
Hyperventilation
Fever, dehydration, severe metabolic acidosis
If not treated: Shock, coma, organ system failure, death

Hypoprothrombinemia – impairment of hemostatis and bleeding

Hypersensitivity – anaphylaxis (mostly pt with asthma, nasal polyps, chronic urticaria)

Symptoms of aspirin intolerance: vasomotor rhinitis, angioedema, urticaria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Aspirin - Interactions and contraindication

A

Adm with antacids: slows absorption rate

Contraindication:
Persons who have has severe hypersensitivity reaction to aspirin or another salicylate should not be treated with another type of NSAID (cross-sensitivity)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ibuprofen - MoA

A

Reversible and nonselective inh of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ibuprofen, Ketoprofen, Naproxen - Clinical use

A

Analgesic, antipyretic and anti-inflammatory effects

Low dose: mild pain & inflammation

Higher dose: arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ibuprofen - Special

A

Combo with H2 receptor antagonist famotidine for RA & OA (less GI ulcers)
Half-life: 2h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Ibuprofen - Adverse

A

GI irritation, nausea, dyspepsia, bleeding.
Long-term: PUD,
Hepatotoxicity, renal toxicity
Failure of ingesting adequate fluid: acute renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Naproxen - Special

A

Combo with esomeprazole: arthritis, reduces risk of ulcers

Longer halflife (14h)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acetaminophen - MoA

A

COX3 inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acetaminophen - Clincal use

A

Mild fever & pain
Mild arthritis

Analgesic and antipyretic effects via inh of COX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Acetaminophen - Special consideration and Overdose treatment

A

Safe for children with viral inf.

Overdose treatment: acetylcysteine

Can be used with other NSAID of supplemental analgesia. Should be avoided.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acetaminophen - Adverse

A

Fewer GI problems
Low doses ok in pregnancy for analgesia & antipyresis

High dose: hepatic necrosis, hepatotoxicity

Long-term use: Increased risk of renal dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Acetaminophen - Interactions

A

Small amount converted by CYT P-450 to potentially hepatotoxic quinone intermediate

Patients at risk for hepatotoxicity (f.ex. overdose): given acetylcysteine (conjugates quinone and renders it harmless)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Indomethacin - Clinical use
Reserved for moderate/severe infl disorders | Patent ductus arteriosus (indomethacin inh synthesis of prostaglandins and causes the closure)
26
Indomethacin - Adverse
Nephrotoxicity with triamterene Highest incidence of GI and CNS side effects Hematologic toxicity
27
Indomethacin - Interaction
Reduces natriuretic effect of diuretics. | With triamterene: nephrotoxicity
28
Sulindac - MoA
Prodrug converted to active sulfide metabolite. Parent compound sulindac sulfoxide is inactive in COX inh
29
Sulindac - Clinical use
RA | Adenomas in polyp disease
30
Ketorolac - Clinical use
Analgesic activity Post-op moderate pain in dentistry Allergic conjunctivitis Post-op ocular infl.
31
Ketorolac - Special consideration and contraindications
Treatment limited to 5 days. Caution in pt with renal/hepatic disease
32
Ketorolac - Adverse
Fewer GI and CNS effects than opioids. Hematologic toxicity Increased risk of renal or hepatic impairment
33
Piroxicam - Clinical use
Anti-inflammatory | Chronic RA treatment
34
Piroxicam - Special
Long half-life (50h)
35
Nabumetone - MoA
Weak COX inhibitory activity in vitro, but converted to active metabolites with potent inhibition in vivo
36
Etodolac, meloxicam - MoA
More selective for COX-2 than typical NSAIDs
37
Diclofenac - Clinical use
Osteoarthritis
38
Selective COX-2 inhibitors
Celecoxib Rofecoxib (Removed from market) Valdecoxib (Removed from market)
39
Selective COX-2 inhibitors - MoA
Potent anti-inflammatory action
40
Selective COX-2 inhibitors - Special
Decreased risk of cancer (esp colon cancer)
41
Celecoxib - Clinical use
Rheumatoid arthritis | Osteoarthritis
42
Celecoxib - MoA
Analgesic, antipyretic, antiinflammatory
43
Celecoxib - Adverse
Increased risk of cardiovascular events | Low incidence: diarrhea, dyspepsia, abd pain
44
Celecoxib - Interactions
Metabolized by CYT P-450, excreted in feces and urine Metabolism is inhibited & increased serum levels by fluconazole, fluvastatin, zafirlukast.
45
Uricosuric drugs
Probenecid Sulfinpyrazone Lesinurad
46
Uricosuric drugs - Clinical use
Prevent gout attacks in persons who under-excrete uric acid.
47
Probenecid - MoA
Increases excretion of uric acid by competitive inhibition of uric acid reabsorption
48
Probenecid - Interactions
Aspirin and salicylates: interfere with the uricosuric effect. High dose of salicylates: inh uric acid reabsorption Low doses of salicylates: inh uric acid secretion
49
Sulfinpyrazone - MoA
Complete inhibition of urate reabsorption, increasing uric acid excretion
50
Sulfinpyrazone - Adverse
GI, renal and hematologic adverse effects
51
Lesinurad - MoA
Reduces uric acid levels by inh the function of transporters responsible for uric acid reabsorption, uric acid transporter 1 and organic anion transporter 4.
52
Xanthiine oxidase inhibitors
Allopurinol and Febuxostat
53
Xanthiine oxidase inhibitors - MoA
Decreases production of uric acid
54
Xanthiine oxidase inhibitors - Clinical use
Prevent gout attacks in people who overproduce uric acid. | Prevent hyperuricemia and gout in persons having cancer chemotherapy and whose rate of purine catabolism is high.
55
Allopurinol - MoA
Competitive inhibitor of xanthine oxidase Converted to active metabolite oxypurinol in the liver. Decrease in uric acid excretion and corresponding increase in urinary excretion of hypoxanthine.
56
Allopurinol - Clincal use
Hyperuricemia and gout in cancer patients with high purine catabolism Prevent the occurrence or progression or both gouty arthritis and urate nephropathy
57
Allopurinol - Adverse
Nausea, vomiting, hepatitis, skin rashes, hypersensitivity.
58
Allopurinol - Interactions
Inhibits catabolism of azathioprine and mercaptopurine
59
Febuxostat - MoA
Competitive inhibitor of xanthine oxidase
60
Febuxostat - Adverse
Liver enzyme elevations, nausea, arthralgia, rash
61
Catabolic enzyme preparations
Pegloticase and Rasburicase
62
Catabolic enzyme preparations - MoA
Reverse hyperuricemia
63
Pegloticase - Clinical use
Refractory chronic gout
64
Pegloticase - Adverse
Life-threatening allergic reactions
65
Rasburicase - Clinical use
ONLY: initial management of plasma uric acid in pediatric and adults with leukemia, lymphoma and solid tumor malignancies who are receiving anticancer therapy
66
Rasburicase - Adverse
Allergic reactions
67
Drugs for treating gout attacks
Indomethacin and Clochicine
68
Indomethacin - MoA
Anti-inflammatory drug for rapid relief of pain
69
Clochicine - MoA
Disrupting microtubules and inh of inflammatory leukocyte motility --> blocking their ability to cause urate crystal-induced joint inflammation.
70
Clochicine - Adverse
Nausea, vomiting, diarrhea, abdominal cramps
71
Indomethacin and Clochicine - Clinical use
Acute gout